Anticancer agent 269
Product Specifications
Target
Apoptosis|||Reactive Oxygen Species|||Caspase|||ROS
Related Pathways
Immunology/Inflammation|||Proteases/Proteasome|||NF-?B|||Metabolism|||Apoptosis
Bioactivity
Anticanceragent 269 (Compound 11c) is an orally active caspase-3 activator that exhibits significant anticancer activity by inducing apoptosis through the activation of caspase-3 and promoting ROS generation. It is a valuable compound for research within the cancer field.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
